Overview
Focuspharma works in the field of next-generation probiotics. It was founded through collaboration between practicing pharmacists and scientists from the Jagiellonian University and the University of Agriculture in Krakow.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 838 days for 2020).
- 2023not filed
- 202216/02/2024
- 202101/02/2024
- 202031/01/2024
- 201930/11/2021
- 201821/09/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
News
Industry
Offer
- Probiotics
- Iron supplements
- Cranberry preparations
- Vitamin C
- Thyme and coltsfoot preparations
Website technology
- Website
- WordPress
Authorized Representatives
Manner of representation
Both where the management board is a one-person management board and where it is a multi-member management board, both the President of the Management Board and each member of the management board acting independently are authorised to represent the company and make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ireneusz Augustynage 62 | 600 | $8,103.73 | 30% |
Jolanta Szułakiewiczage 50 | 1,200 | $16,207.46 | 60% |
Others | 200 | $2,701.24 | 10% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2015-06-01 to 2025-05-19.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Kraków | |
| Nov 6, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $0$0 | Marszałek Małopolski |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $1,364,908,839.78 | polpharma.pl | ||
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Sciencepharmasp. z o.o. | $111,783,976.52 | sciencepharma.com | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $40,633,950.51 | biomed.pl | ||
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | ||
| Biofaktorsp. z o.o. | $10,761,755.73 | biofaktor.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-09-13 | Share capital increase (5,000.00 PLN → 100,000.00 PLN) | |
| 2015-05-12 | Entered in the register |
FAQ
Last updated: 2026-04-12